March 2, 2020
IMMUNOPRECISE and EVQLV are collaborating on accelerating the global effort to develop lead vaccine candidates against the SARS-CoV-2 virus.
May 1, 2019
The second day of the show had more company presentations, interviews and a panel discussion on R&D-stage healthcare companies.
April 2, 2019
ImmunoPrecise (TSXV:IPA, OTC Pink:IPATF) has announced the launch of DeepDisplay, a combination of transgenic animal immunization and custom phage display...